Abstract-Reactive oxygen species and reactive nitrogen species are biological molecules that play important roles in cardiovascular physiology and contribute to disease initiation, progression, and severity. Because of their ephemeral nature and rapid reactivity, these species are difficult to measure directly with high accuracy and precision. In this statement, we review current methods for measuring these species and the secondary products they generate and suggest approaches for measuring redox status, oxidative stress, and the production of individual reactive oxygen and nitrogen species. We discuss the strengths and limitations of different methods and the relative specificity and suitability of these methods for measuring the concentrations of reactive oxygen and reactive nitrogen species in cells, tissues, and biological fluids. We provide specific guidelines, through expert opinion, for choosing reliable and reproducible assays for different experimental and clinical situations. These guidelines are intended to help investigators and clinical researchers avoid experimental error and ensure high-quality measurements of these important biological species. *Drs Griendling and Touyz contributed equally to this work. The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
antioxidants are effective therapies in cardiovascular medicine. Yet the belief remains that oxidative stress contributes to many cardiovascular pathologies. Putative reasons for this paradox relate to the relatively weak nature of the antioxidants used in clinical trials, an incomplete understanding of the complex molecular mechanisms whereby ROS cause pathological changes, the difficulty in extrapolating findings from experimental models to clinical scenarios, and the methodological challenges relating to accurate measurement of ROS in the cardiovascular system.
Although myriad techniques, protocols, assays, and commercial kits have been developed to measure ROS, and numerous biomarkers have been used to study human oxidative stress, many of these assays are used inappropriately or without due experimental diligence, resulting in potential inaccuracies and artifacts, as well as much confusion in the literature. Moreover, the cardiovascular researcher who is a novice in the field of free radical biology may be overwhelmed in choosing from the many tools and methods currently available to measure ROS, RNS, and oxidative stress.
Objectives
The purpose of this scientific statement is to review current methods for measuring ROS, RNS, and their secondary products; to discuss the strengths and limitations of specific methodological approaches; and to provide guidelines, through expert opinion, for reliable and reproducible techniques for quantifying these species and for elucidating their role in redox-dependent signaling and cell injury. Because of the diversity of experimental systems in which the roles of these species are interrogated, we offer here only general methodological guidelines and assistance with decisions as to which assay to choose. This review does not focus on specific protocols, and the reader is referred to appropriate methodology-based articles for specific protocols. Measurements of ROS and RNS in clinical studies are discussed separately to recommend a distinct set of measurements that should be made to assess systemic oxidative stress and to document oxidative injury in clinical scenarios.
Background
Chemically reactive molecules containing ROS or RNS are generated endogenously in most cells during the course of normal metabolism, during disease development, and in response to tissue injury. These species are also produced on exposure to exogenous insults such as environmental pollutants, tobacco smoke, and ionizing radiation. Most ROS and RNS are relatively unstable oxygen-or nitrogen-centered free radicals that contain unpaired electrons (biological half-life is microseconds to milliseconds); however, these species also include more stable species such as peroxides and nitrosothiols (biological half-life is seconds). Major ROS and RNS generated in biological systems are listed in Table 1 .
Although nitrogen itself is a stable diatomic gas, molecular oxygen in the ground state is a free radical with 2 unpaired electrons in its outmost shell. Because both these electrons have parallel spin, diatomic oxygen is relatively unreactive. However, during its utilization in the mitochondria, oxygen accepts 1 electron at a time, which leads to the generation of partially reduced species such as superoxide (O 2 . − ). Hydrogen peroxide by itself is fairly unreactive, but it oxidizes Fe(II) to Fe(III) to generate hydroxyl radicals in a process known as the Fenton reaction. 1, 2 In vitro, O 2 . − can reduce the oxidized metal generated by the Fenton reaction to regenerate Fe(II) (Haber-Weiss reaction); however, the in vivo identity of the reductant is less clear, and Fe(III) can be reduced with variable efficiency by a variety of cell reductants. In addition to iron, other metals such as Cu, Cr, Co, V, and to a lesser extent Ni can catalyze Fenton chemistry, 3 but in most biological systems the role of iron is critical. In most vertebrates, iron is bound to ferritin, which oxidizes Fe(II) at the ferroxidase center, thereby decreasing Fe(II) available for the Fenton reaction. 4 Notably, dysregulation of iron homeostasis because of injury or hereditary ferritinopathies results in increased oxidative damage. In the mitochondria, destruction of the [4Fe-4S] cluster (eg, aconitase) can also result in the release of Fenton-active Fe(II), leading to increased ROS production. 5 This could be a mechanism whereby non-Fenton metals (such as Ag and Hg) exert toxicity by increasing ROS production. 6 The hydroxyl radical generated by the Fenton reaction is extremely reactive and short-lived. It reacts indiscriminately with most cell constituents and leads to the generation of secondary free radical species that deplete antioxidants and oxidize thiols and unsaturated lipids. In contrast to the indiscriminate reactivity of the hydroxyl radicals, ROS generated by enzymatic reactions such as those catalyzed by nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, cytochrome P450 enzymes, and glucose oxidase are generally considered to serve signaling functions, although localized generation of hydroxyl-like species (eg, in the endoplasmic reticulum) could also affect the expression of specific genes or their coactivators.
Introduction
Many methods have been devised to measure oxygen free radicals and their derived oxidants with various levels of sensitivity and accuracy. These include chemical assays for O 2 . − , H 2 O 2 , or
• OH generation, direct chemiluminescent assays or measurement of signal in the presence of chemiluminigenic probes, fluorescence detection in the presence of redox-sensitive probes, and either direct or spin trapping-based electron paramagnetic resonance (EPR) spectroscopy. Only EPR enables the direct detection of free radicals, but other assays can be informative if used with proper controls.
Measurement of Superoxide Anion Radical (O 2 . )
− − EPR Assay: EPR Spin-Trapping EPR spectroscopy is the "gold standard" for unambiguous assessment of oxygen-centered free radical generation in biological systems. EPR, also known as electron spin resonance, is a method to detect molecules with unpaired electrons. When combined with an appropriate spin trap, it is a powerful and reliable technique to unequivocally measure O 2 . − ,
• OH, and NO in biological samples (for NO, see Measurement of RNS).
A variety of spin traps have been used to detect and quantify free radicals in cardiovascular tissues. Spin trapping with DMPO (5, 5-dimethyl-1-pyrroline-N-oxide) is the strategy most widely used to detect O 2 . − or
• OH generated in endothelial cells 9, 10 or myocytes (see Table 2 for comparison of spin traps). [11] [12] [13] [14] DMPO has also been used to assay for mitochondria-derived O 2 . − generation by EPR. 13 , 15 Because of the short half-life of DMPO/
• OOH (t 1/2 ≈45 seconds) and OH is often detected. Therefore, a suitable SOD, polyethylene glycol-conjugated SOD (PEG-SOD), or SOD mimetic must be used to confirm that the detected DMPO/
• OH is dependent on the formation of O 2 . − . [16] [17] [18] To distinguish O 2 . − from
• OH in biological systems or for in vivo
• OH detection, DMSO (dimethyl sulfoxide), a specific hydroxyl radical scavenger, is used. 19 An alternative to DMPO is DEPMPO [5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-Noxide], a diethoxylphosphoryl derivative of DMPO, which has the advantage that it forms a more stable O 2 . − adduct (t 1/2 ≈15 minutes). 20 PBN (α-phenyl-N-t-butylnitrone) or POBN [α-(4-pyridyl-1-oxide)-N-tert-butylnitrone] have been used effectively for in vivo spin trapping of ROS production. 21, 22 Although these traps are useful for trapping O 2 . − -derived hydroxyl and alkyl radicals, stable O 2 . − adducts are not typically formed with PBN or POBN. In vivo or in situ direct EPR or EPR spin trapping with DMPO has been demonstrated in the Langendorff-perfused heart, which provides direct evidence of O 2 . − generation during myocardial ischemia and reperfusion injury. 11, 14, 23, 24 These measurements also detect the carbon-centered radical formed by ischemia and reperfusion injury-mediated lipid oxidation or lipid peroxidation (DMPO/ • R). 14, 24 Ex vivo EPR spin trapping with DMPO has been used recently to quantify mitochondria-derived O 2 . − in the rat heart. 15 DEPMPO has been used extensively to investigate molecular mechanisms of ROS generation mediated by enzymes such as endothelial NOS (eNOS), 25 NADPH oxidases, xanthine oxidase, 26 and the mitochondrial electron transport chain in vitro. [27] [28] [29] [30] In summary, EPR spin trapping with either DMPO or DEPMPO is a useful approach for measuring oxygen-, carbon-, nitrogen-, and sulfur-centered radicals. These spin traps can measure O 2 . − generation in cells, as well as O 2 . − or • OH generation mediated by cardiovascular enzymes and mitochondria in vitro and in the isolated heart ex vivo. However, when used with tissues or cells, they have the limitation that spin adducts can be converted to EPR silent products, so that failure to detect a signal does not rule out low-level radical generation. 31 In vivo spin trapping of ROS with nitrones can be performed but might not provide the adduct stability and resultant sensitivity to detect low levels of radical generation. Recent advances in the development of stabilized/protected nitrone spin traps bound to cyclodextran or calixpyrrole groups offer promise in addressing this limitation. 32, 33 Alternative approaches for the detection of spin trap adducts or their metabolites include high-performance liquid chromatography (HPLC) and mass spectroscopy, 34, 35 high-field nuclear magnetic resonance, 36 and antibody-immune based detection.
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EPR Assay: Spin Probes With Cyclic Hydroxylamine or Other Hydroxylamines
Several cyclic hydroxylamines, including CM-H (1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine), CP-H, PP-H, CAT1-H, and mitochondria-targeted mitoTEMPO-H, have been used widely as spin probes to measure O 2 . − production in the cardiovascular system, an approach that requires confirmation with SOD, PEG-SOD, or SOD mimetics. 31, 39, 40 Cyclic hydroxylamines react rapidly with O 2 . − , producing stable nitroxides, and allow site-specific O 2 . − detection in the intracellular, extracellular, and mitochondrial compartments. However, 1-electron oxidation of cyclic hydroxylamine to nitroxide is also mediated by other cellular oxidants, including H 2 O 2 , peroxynitrite, hypochlorite, and compound I-and compound II-like species. This makes it necessary to use specific scavengers to identify the oxidant generating the signal. Because of their favorable cell permeability, cyclic 
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hydroxylamines can be used as spin probes to determine the redox status of the cardiovascular system in situ by EPR redoximetry as described in Measurement of Redox Status. CM-H has been used to detect intracellular O 2 . − in cultured cells and tissue samples. To minimize hydroxylamine autoxidation, the spin probe solution must be prepared in argonbubbled ice-cold NaCl in the presence of the chelating agent diethylenetriamine-penta-acetic acid or a combination of deferoxamine and diethyldithiocarbamate. 31 In complex in vivo systems, O 2 . − -independent oxidation of the hydroxylamine to the nitroxide is possible, and the nitroxide product could be reduced enzymatically. Hence, these possibilities should be considered and appropriate controls included, such as SOD, PEG-SOD, or SOD mimetics. 31, 39, 40 EPR with the spin probe CM-H has been used to detect and quantify angiotensin II (Ang II)-induced and Nox1-dependent O 2 . − production in the aorta, 39 as well as NADPHand xanthine oxidase-dependent O 2 . − production in models of atrial fibrillation. 40 EPR with the cyclic hydroxylamine spin probe is an effective approach for studying intracellular O 2 . 
. 41 In vitro studies suggest that the reactivity of O 2 . − with these TAM probes is much higher than that of EPR with TAM has been applied to monitor NADPH oxidase-mediated O 2 . − release from stimulated neutrophils, endothelial cells, and other cellular systems. 41 TAM spin probes enable simultaneous measurements of O 2 . − and oxygen concentration and consumption in biological systems associated with respiratory burst and anoxia-reoxygenation. 42 The probe CT02-H is more sensitive than nitrone spin traps in measuring low O 2 . − flux. It is also uniquely well suited for in vivo EPR imaging applications (see Measurement of Redox Status).
Cytochrome c Reduction Assay
Cytochrome c (or acetylated cytochrome c) reduction is another assay used to measure O 2 . − production in vascular and myocardial cells and tissue. 40, 43, 44 Ferricytochrome c accepts an electron from O 2 . − to form ferrocytochrome c, which results in an increase in absorbance at 550 nm. As a control, the assay must also be performed in the presence of SOD or PEG-SOD. Acetylation of cytochrome c reduces the charge effect of the lysine residues of cytochrome c; thus, use of acetylated cytochrome c improves the electron transfer specificity for O 2 . − . 45 Potential drawbacks of the use of cytochrome c relate to its reactivity in biological systems. Both cytochrome c and acetylated cytochrome c show peroxidase activity in the presence of ROS because of oxidation of the sixth heme ligand methionine. 46 Furthermore, cytochrome c can be reduced by a variety of biological reducing agents, including the NOS and P450 reductases. In the mitochondrial system, higher electron transfer efficiency mediated by complex III than from O 2 . − to cytochrome c limits its usefulness.
A suitable mitochondrial inhibitor and SOD should be used to distinguish whether the reduction of ferrocytochrome c is caused by electron leakage or electron transfer. Thus, depending on the system, specificity could be a concern. Controls with SOD, PEG-SOD, or an SOD mimetic or other appropriate scavengers are essential. The cytochrome c reduction assay has been used to measure O 2 . − production in biological systems in vitro and occasionally ex vivo. 44 50 The most unequivocal and quantitative detection of intracellular O 2 . − by 2-OH-E + in tissue specimens can be obtained with an HPLC equipped with a fluorescence or electrochemical detector, or by liquid chromatography (LC)/mass spectrometry (MS). 31, 51 In combination with the technique of EPR redoximetry, DHE or hydroethidium has been used to monitor O 2 . − production during myocardial ischemia and reperfusion in vivo 52 and ex vivo. 53 In situ DHE imaging of O 2 . − generation in the myocardium has been applied in experimental models of cardiac hypertrophy induced by pressure overload. 54 DHE has also been used extensively in the vasculature. [55] [56] [57] Combined with HPLC instrumentation, 2-OH-E + formation from frozen myocardial tissue extracts preincubated with DHE has been reported as the indicator of O 2 . − production associated with pathological cardiac hypertrophy. 58 In all of the above applications, it is critical that appropriate controls with SOD, PEG-SOD, or SOD mimetics are used. 59 When combined with HPLC and LC/MS instrumentation, the DHE probe and the fingerprint of 2-OH-E + are a useful approach to measure and quantify intracellular O 2 . OH than other ROS. Hydro-Cy3 and deuteron-Cy3 have been used to detect Ang II-mediated intracellular ROS production from aortic muscle cells and ROS production in en face preparations of live and explanted aortas. 60 In the mouse model of lipopolysaccharide-induced acute inflammation, hydro-Cy7 has been used to image in vivo ROS generation by activated macrophages and neutrophils. 60 As with other fluorescent dyes, SOD controls are important to ensure specificity. The validity of the lucigenin assay has been questioned because O 2 . − is generated by lucigenin itself. 69 Lucigenin can uncouple flavoenzymes, thus triggering O 2 . − in a concentration-dependent manner. The concentration of lucigenin used is therefore a critical parameter affecting the validity of this assay. 70 It has been shown that the concentration of lucigenin should be ≤5 μmol/L, and extensive controls are required to rule out redox cycling. 71, 72 It is also important to document that the concentration used does not significantly increase oxygen consumption. Higher concentrations of lucigenin can attenuate endothelium-dependent relaxation by acetylcholine and have been shown to uncouple eNOS. 70 An additional consideration is the concentration of NADPH used in cell-free assays. NADPH at a concentration of 100 μmol/L is most commonly used, because higher concentrations can lead to aberrant results. Thus, lucigenin is only useful if used at low concentrations (≤5 μmol/L) in fractionated cells or tissues with the appropriate concentration of NADPH, as well as SOD controls.
Mitochondria-Specific Fluorescent Probes
Recommendations for Measurement of O 2
. − − Figure 1 70 If lucigenin is used, it should be complemented with a second, independent assay. Similar considerations should also be applied to coelenterazine.
Combined with appropriate SOD controls, fluorescence analysis with DHE is a useful approach to measure and image intracellular O 2 . − production from cells and tissues because of its high sensitivity. Ideally, it should be combined with HPLC to ensure specificity. DHE should only be used in cells containing DNA. Mitochondria-specific fluorescent probes are useful for qualitative assessment, for example, ROS localization, but not for quantitative studies. Localization of ROS production can be confirmed by supplementation with cell-impermeable Cu,Zn-SOD, cell-permeable PEG-SOD, or mitochondria-targeted antioxidants such as mitoTEMPO. 57 Hydrocyanines and deuterocyanines are useful as fluorescence probes with high persistence and high sensitivity, but further work is needed to characterize their specificity. These fluorescence-based methods are useful in a wide range of applications including translational research from patient-derived cells and tissues.
The 73 In combination with spin-trapping agents, electrochemical detection is effective for distinguishing the production of H 2 O 2 and O 2 . − that results from NOS uncoupling. 74 Electrochemical detection is useful in assessing H 2 O 2 generated by isolated enzymes and for measuring H 2 O 2 metabolism in the isolated mitochondria and cellular systems. However, this method is not widely used for in vivo measurements because of its poor sensitivity and difficulties with in vivo use of polarographic electrodes.
Amplex Red
In the presence of H 2 O 2 , Amplex Red is oxidized efficiently by horseradish peroxidase to a fluorescent product, resorufin, which can be measured using a fluorescent plate reader. The assay is a feasible and reliable method to measure extracellular H 2 O 2 in vessels 75 and the heart. 76, 77 The assay is also highly effective for assessing extramitochondrial H 2 O 2 generated from isolated myocardial mitochondria 76, 77 and has been used to measure H 2 O 2 released from mouse aorta. 31, 75 It has also been used to quantify external H 2 O 2 released from mitochondria of the ischemic heart. 76 The Amplex Red assay is highly recommended for measuring H 2 O 2 released from mitochondria, cells, vessels, and cell-free systems. However, in tissues, the product (resorufin) induces nonspecific oxidation via other oxidant and radical-mediated reactions. Therefore, controls to correct for the fluorescent background must be performed with addition of SOD and catalase.
Dichlorodihydrofluorescein Diacetate
Dichlorodihydrofluorescein diacetate (DCFH-DA) is a cellpermeable and widely used probe to detect intracellular production of H 2 O 2. It is commonly used for measuring H 2 O 2 or oxidant stress in cells or tissues in combination with confocal microscopy or flow cytometry. DCFH has been used to image H 2 O 2 in vessels and to evaluate mitochondrial H 2 O 2 as the source of flow-induced dilation in coronary resistance arteries, 78 as well as H 2 O 2 levels of carotid artery and aortic smooth muscle cells during the progression of atherosclerotic lesion development. 79 DCFH-DA has also been used to explore iron-mediated redox-signaling mechanisms in the cardiovascular system 80 85, 86 HyPer is useful in monitoring intracellular H 2 O 2 in situ. A major advantage is that it is genetically encoded and so can be targeted to specific compartments, such as the endoplasmic reticulum and mitochondria. 87 Care must be taken, however, to avoid quenching of H 2 O 2 in these compartments by the presence of the probe. Moreover, despite its high specificity for H 2 O 2 , the fluorescence signal of cytosolic HyPer can respond to pH changes, decreasing with acidosis and increasing with alkalosis. Thus, the HyPer assay should be conducted with side-by-side pH monitoring. 88 Furthermore, the HyPer fluorescent response can adapt to repeated oxidation and can be insensitive to reducing stimuli. HyPer responses thus must be interpreted carefully. 88 Recent modifications (eg, HyPer-3) have overcome some of these difficulties and allow expanded dynamic range and ratiometric imaging. 
Mitochondrial Probes
MitoB ([3-hydroxybenzyl]triphenylphosphonium bromide) accumulates in the mitochondria by virtue of a triphenylphosphonium cation component. The arylboronic moiety of MitoB reacts with H 2 O 2 to form a phenol product, MitoP, in the mitochondrial matrix. H 2 O 2 concentration is determined by assessing the ratio of MitoP to MitoB as measured by MS with d15-MitoP and d15-MitoB used as standards. 90, 91 As such, this assay can be used in cultured cells and tissue. A limitation of this method is the need for sophisticated equipment not readily available in many laboratories.
Dickinson and Chang 92 recently described a mitochondriatargeted boronate-based peroxy yellow 1 probe containing a triphenylphosphonium group that allows selective detection of H 2 O 2 within the mitochondria (MitoPY1). This new fluorescent probe permits imaging H 2 O 2 within the mitochondria of living cells using confocal microscopy and flow cytometry. 
Recommendations for
Measurement of Redox Status
Redox status refers to the tendency or ability of the tissue or cell to accept (more oxidized) or donate (more reduced) electrons. The biological redox status is often reflected by the balance of GSH (reduced glutathione)/GSSG, NAD + / NADH, and NADP + /NADPH in a cell or organ, as well as by the balance of several sets of metabolites (eg, lactate and pyruvate, β-hydroxybutyrate, and acetoacetate) whose interconversion is dependent on these ratios, free radical reactions, and reversible/irreversible modifications of redox proteins. Although abnormal redox status has been linked to several conditions such as hypoxia, ischemia and reperfusion, hypertension, atherosclerosis, shock, and sepsis, accurate assessment of redox status is difficult. EPR-based techniques and measurement of redox couples such as GSH/ GSSG and cysteine/cystine (Cys/CySS) represent the most common approaches. The NADPH/NADP + ratio is also an important determinant of the cellular redox status, but it is difficult to measure because no methods are available to measure the concentration of free NADPH or NADP + in the cell. The NADH:NAD + ratio, however, can be estimated indirectly by measuring the pyruvate to lactate ratio, which is regulated by the reaction catalyzed by lactate dehydrogenase, although in such measurements it is important to ensure that the reaction is at or near equilibrium. 93 Levels of free NAD + /NADH can also be measured with newly developed biosensors or nuclear magnetic resonance using the magnetic enhancement technique, 94, 95 but these methods will not be discussed further here.
EPR Redoximetry With Spin Probe Hydroxylamines and Nitroxides
In oxidized conditions such as those in the postischemic myocardium, cyclic hydroxylamines can serve as a redox substrate to determine the redox activity of tissue specimens using EPR. The assay can be combined with a nitroxide probe such as TEMPOL to assess the level of reductive stress in the tissue specimen. This approach is applicable to in vivo measurements of whole animals and translational research using human samples; however, it cannot determine the redox status of thiols that are involved in oxidative posttranslational modifications (Oxidative Modification of Proteins). To obtain a complete picture of redox status, additional assays should be conducted, including analysis of GSH and GSSG (by an enzymatic recycling assay), measurement of free thiols by the biradical spin probe RSSR [bis-(2,2,5,5-tetramethyl-3-imidazoline-1-oxyl-4-yl) disulfide], redox immunoblotting to assess protein oxidation, and HPLC analysis of oxidatively modified amino acids.
In Vivo Redoximetry With Low-Frequency EPR Spectroscopy and Imaging
In vivo redoximetry provides noninvasive in situ measurement of redox status. With the use of nitroxide probes, this approach has proved useful in monitoring in situ redox alterations of the myocardium during ischemia and reperfusion. [96] [97] [98] Nitroxides are paramagnetic and are reduced or reoxidized depending on the redox environment. By measuring the shift of redox status from more reduced to more oxidized, one can determine how redox alterations correlate with disease progression. 52, 96 Trityl-nitroxide is a biradical that can also be used for in vivo redoximetry. With this biradical, the sharp trityl signal increases with nitroxide reduction as opposed to the loss of the nitroxide EPR signal. It can be used to simultaneously monitor oxygenation and redox alterations. 99 With the addition of magnetic field gradients, EPR images of the free radical probe and its reductive clearance can be performed. [100] [101] [102] This oxy-redoximetric assay is highly promising, and ex vivo cardiac applications have been performed with nitroxide probes. 103 For in vivo redoximetry using nitroxides, it is important to confirm that the signal decay is caused by reduction of the nitroxides to the diamagnetic hydroxylamine. The hydroxylamine can be reoxidized to paramagnetic nitroxide by ferricyanide. Ferricyanide is thus used to confirm reduction to the hydroxylamine. In vivo EPR redoximetry is considered to be the "gold standard" for measuring redox physiology in the in vivo setting under physiological and pathological conditions.
In Vivo Redox Imaging Using Proton-Electron DoubleResonance Imaging
This approach utilizes the Overhauser effect to enable in vivo imaging of free radicals in the heart. The redox state of the tissue is measured by combining a nitroxide spin probe or biradical with proton-electron double-resonance imaging (PEDRI) instrumentation, enabling nuclear magnetic resonance/magnetic resonance imaging-based detection and imaging of the redox state based on saturation of the EPR resonance. As described above, nitroxide spin probes enable measurement of the tissue redox state based on their reduction to diamagnetic hydroxylamines. 93, 98, 101 PEDRI instrumentation enables imaging of the in vivo distribution and metabolism of nitroxide radicals in living mice, which enables the redox status of the vascular system to be visualized. 98 PEDRI has been applied to image nitroxide radicals in the isolated beating rat heart, with visualization of radical uptake, distribution, and clearance. 101 When PEDRI is applied to acquire in vivo redox images of the beating heart using nitroxides as the redox-sensitive probe, a nitroxide radical with longer relaxation time and sharp EPR line width can offer better sensitivity. In vivo, PEDRI provides an enhanced form of in vivo redoximetry along with spatial mapping. It is a powerful tool for measuring and visualizing the redox distribution and clearance in the isolated heart and in animal models of disease, but it requires very specialized equipment and expertise that are not commonly available in most laboratories. 
GSH/GSSG and Cys/CySS
A simpler method for estimating redox potential is assessment of the ratio of the concentration of reduced to oxidized glutathione or reduced to oxidized Cys. As the most abundant redox couple in the cell, and because it is maintained by the combined activity of several redox couples, GSH/GSSG is a useful indicator of redox status and correlates with many cell functions, such as proliferation, differentiation, and apoptosis. 104 Virtually all cardiovascular cell types express transporters for GSH, GSSG, Cys, and CySS, so that redox potentials measured in plasma reflect tissue redox state, but only indirectly. GSH can be measured using enzymatic recycling of GSSG reductase, HPLC with UV detection, and electrochemical detection, but these methods are not sensitive enough to detect low levels of GSSG. A better assay uses iodoacetate to alkylate free thiols, derivatization with dansyl chloride to fluorescently tag amino groups, and HPLC and fluorescence to separate, detect, and quantify GSH, GSSG, Cys, and CySS. 105 Subsequent calculation of the nonequilibrium redox potential (E h GSH or E h Cys) is a reflection of the redox state of the tissue of interest. During the assay, care must be taken to prevent oxidation and degradation. These measurements can be performed in plasma, tissue biopsy specimens, and cultured cells. 105 Ashfaq et al 106 showed that E h GSH/GSSG in plasma correlates with changes in intima-media thickness, a subclinical indicator of atherosclerosis.
RoGFP
Another fluorescence-based method to measure redox status involves the use of reduction-oxidation sensitive green fluorescent protein (RoGFP) probes. 107 These probes consist of a green fluorescent protein in which 2 cysteines were introduced, the oxidation state of which serves as a readout of redox status in the particular subcellular compartment in which the RoGFP is expressed. When a disulfide bond is formed within the molecule, its fluorescent properties are altered such that there is a reciprocal change in emission (525 nm) after excitation at 2 different wavelengths (400 and 484 nm). 108 This ratiometric property makes the signal independent of expression levels of the probe. Another advantage is the ability to add a targeting sequence so that the probe is expressed in specific subcellular compartments. 109, 110 Early versions of this probe (RoGFP2) are sufficient for reducing environments such as the cytosol and mitochondria. Subsequent modifications, in which the thermodynamic stability of the disulfide is lowered by inserting a single amino acid adjacent to one of the cysteines (eg, roGFP1-iL), 111 have rendered the redox potential closer to that of the endoplasmic reticulum. Thus, one must know the redox potential of the compartment to be studied and choose the version of RoGFP that most closely aligns with it. RoGFP has been used successfully to measure redox status in the cytosol, mitochondria, and mitochondrial inner membrane space in vascular smooth muscle cells exposed to hypoxia as well as glutathione-induced reductive stress in the heart.
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Recommendations for Measurement of Redox Status Introduction
The short half-life of NO in biological systems presents unique challenges for its detection and quantification. 113 NO is lipophilic and diffuses rapidly through cells. The main sources of NO include NOS and reductive metabolism of nitrite (NO 2 − ) and RSNO. 114 In biological systems, NO is rapidly oxidized by several nonenzymatic and enzymatic pathways. In the vasculature, NO is oxidized by oxyhemoglobin to nitrate (NO 3 − 
Detection of NO
Detection of NO in biological systems is complicated because of its short half-life, contaminants in laboratory reagents, and the multiple reactions that it undergoes, leading to a variety of end products. Because of their short half-lives, most RNS cannot be detected in frozen or fixed tissue samples, but they can be detected in live tissue or intact cells.
Colorimetric (Griess Reaction) and Related Methods
In the Griess reaction, nitrite-containing media is first treated with sulfanilamide in acidic media to form a transient diazonium salt, which then reacts with a coupling reagent, Nnaphthyl-ethylenediamine, to form a stable azocompound. These products can be measured by spectrophotometry, fluorescence, 117 or HPLC. 118 A major problem with the unmodified Griess reaction is its relative insensitivity (≈500 nmol/L), which makes measurements of endothelium-derived nitrite difficult. With this method, it is feasible to measure the production of nitrite generated by the inducible or neuronal NOS isoforms, which have higher V max values. The sensitivity of the method can be enhanced 10-fold by fluorometric detection, which makes it suitable for clinical applications. 117 Another drawback of the Griess reaction is that a substantial portion of NO production by NOS enzymes is oxidized to nitrate, which is not detected by this technique unless NO is reduced to nitrite by a nitrate reductase reaction.
Nitrite and nitrate contaminants in laboratory reagents often yield strong signals that can overwhelm true biological responses. In pathological states in which NO is oxidized rapidly, its bioavailability is reduced, but nitrate and nitrite levels are not affected. Diet is a major source of nitrite and nitrate and must be controlled for, particularly when measurements are made in the plasma. The main advantage of measuring nitrite and nitrate is that these products are relatively stable. Nitrate and nitrite are incapable of eliciting vasodilatation or other signals themselves; however, they can be biologically relevant because they can generate NO via nitrate reductases or on reaction with deoxyhemoglobin.
Fluorescent Techniques
There are several fluorescent probes for detecting NO based on diaminofluorescein (DAF), including DAF-2 and DAF-FM. DAF-FM is significantly more photostable than DAF-2 and is thus more sensitive for NO detection. 120 The NO detection limit for DAF-FM is ≈3 nmol/L 120 versus ≈5 nmol/L for DAF-2. 121 In this assay, cells are loaded with DAF-FM, washed, and analyzed for DAF-FM fluorescence by either a fluorescent plate reader, fluorescence microscopy, HPLC, or occasionally by flow cytometry. 122 NO donors are generally used as a positive control. Some samples should also be preincubated with NOS inhibitors such as L-NAME (
-(1-iminoethyl)-L-ornithine hydrochloride] to ensure specificity of the signal.
A potential problem with DAF-2 and DAF-FM is that ascorbic acid and dihydroascorbic acid react with these probes and reduce their ability to detect NO. 123, 124 This reaction is concentration dependent, and as long as the concentrations of ascorbic acid and dihydroascorbic acid are stable, this issue does not affect the semiquantitative value of these probes.
Chemiluminescence
Ozone-based chemiluminescence provides sensitive NO detection. 125 Liquid samples from either cells or vessels are injected into a reflux chamber that contains inert gas (nitrogen or argon), which carries NO to the NO analyzer where it reacts with ozone to produce the excited state NO 2 *, which emits light on decay. 126 Typically, the reaction chamber that contains either sodium iodide (NaI) in acetic acid or vanadium in hydrochloric acid is maintained at 100°C. When NaI is used, nitrite is converted to NO, whereas vanadium can reduce both nitrite and nitrate. Other 1-electron oxidation state nitroso species, such as nitrosothiols, can also be detected with this approach. To differentiate between RNS without having to change reaction solutions, samples can be pretreated with RNS-specific reagents before analysis. 127 Recently, an improved method for detecting NO with chemiluminescence has been reported that uses a reaction with soluble guanylyl cyclase-luciferin-luciferase. 128 This approach is based on NO-mediated activation of soluble guanylyl cyclase, which catalyzes the conversion of GTP to cGMP and inorganic pyrophosphate. The assay measures the pyrophosphate, which is converted into ATP with the help of ATP sulfurylase. The resulting ATP activates the luciferin-luciferase reaction, which yields light. This approach allows detection of NO in the low nanomolar range.
Electrochemical Approaches
NO can be detected with microelectrodes, most often coated to be selectively permeable to NO and to eliminate other oxidizable substances. 126 For example, polymerization of o-phenylenediamine on the electrode can increase NO specificity. 126 In electrochemical detection, the voltage of an electrode is controlled to catalyze NO oxidation on the electrode surface. The current generated is a linear function of NO concentration at the electrode surface. 126 This approach requires shielding from extraneous electrical signals, usually by a Faraday cage. In addition, it is essential that the electrode be placed at a constant distance from the source of the NO, for example, a set distance from the cell surface, using a micromanipulator. An advantage of electrochemical detection is that the sample size can be quite small; however, the commercially available devices purported to measure NO are insensitive to the low levels released by endothelial cells. Measurements of NO by this approach are less sensitive than those obtained with lipophilic probes, such as Fe[DETC] 2 (DETC=N, N-diethyldithiocarbamate) (see Electron Paramagnetic Resonance below). This is likely because of the lipophilic nature of NO and the integrative effect of the trap.
NO can also be measured with hemin-functionalized graphene transistors with subnanomolar sensitivity. 129 The graphene is noncovalently functionalized with hemin chloride to form an NO sensor, because hemin has a high binding constant and high selectivity toward NO.
Electrochemical detection with NO electrodes has been used in studies of cultured cells and tissue. 126, 130 Common challenges in such measurements include the specificity of the electrode to NO, the reproducibility of results with different electrodes, and the dependence of data on the distance of the electrode from the cell surface.
Electron Paramagnetic Resonance
EPR is an extremely specific and sensitive approach to detect NO in biological systems. Because of its short half-life and very short relaxation time, NO cannot be directly detected by EPR; however, compounds such as the nitronyl nitroxides PTIO (2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide) and 2 , in contrast, specifically react with NO radical to produce relatively stable complexes with specific EPR spectra, which provides unambiguous NO detection.
A natural spin trap for NO is hemoglobin. On reaction with NO, ferrous hemoglobin forms a stable hemoglobin-NO complex that yields specific high-resolution spectra in rat and mouse blood. 133, 135 Typically, blood is snap-frozen in a tuberculin syringe and placed in a liquid nitrogen quartz Dewar flask designed for low-temperature EPR. 135 The average lifetime of hemoglobin-NO is 4 hours, and it can accumulate in the blood in substantial concentrations. Blood hemoglobin-NO levels have been used to estimate vascular NO production; however, other sources of NO, such as inducible NOS or neuronal NOS, also likely contribute to the signal. 133 Indeed, endotoxin-induced inflammation has been shown to increase the electron spin resonance hemoglobin-NO signal. 136 The contribution of inducible NOS and eNOS in the circulating hemoglobin-NO can be determined by treating experimental animals with specific NOS inhibitors such as 1400W and L-NIO or by using mice deficient in specific NOS enzymes. 133 It should also be kept in mind that dietary nitrite can be reduced to NO by deoxygenated hemoglobin and yield an identical hemoglobin-NO signal; however, this can be minimized by use of a standard or low-nitrate/nitrite diet. 133 The hemoglobin-NO signal in humans is very difficult to detect, likely because of lower levels of hemoglobin-NO and a shift to the low-resolution EPR spectra of 6-coordinate hemoglobin-NO. . − , reacts with thiols, lipids, proteins, and DNA, which makes it very short-lived. 141 Excessive production of OONO − contributes to cellular and end-organ dysfunction in inflammation and cardiovascular disease. 141 Peroxynitrite rapidly oxidizes tetrahydrobiopterin and thus induces eNOS uncoupling and vascular dysfunction. 142 Its reaction with lipids leads to formation of isoprostanes and highly reactive ketoaldehydes, which can be used as indirect measures of OONO − . Peroxynitrite is also frequently measured by accumulation of stable nitration products such as 8-nitroguanine 143 and nitrotyrosine. 144 Other methods include EPR detection with spin probes and spin traps such as CM-H and EMPO [5-(ethoxycarbonyl 
The recently developed boronate probes have proved useful in direct detection of peroxynitrite and related species. 66 Uric acid has been used as a relatively specific scavenger of peroxynitrite.
Thus, inhibition of boronate, CM-H or luminol signals with BH 4 or uric acid can provide confirmation of peroxynitrite detection.
Dihydrorhodamine and luminol chemiluminescence have often been used to detect peroxynitrite; however, these probes undergo nonspecific oxidation in the presence of other oxidants and are therefore not specific for peroxynitrite. Their use is not recommended unless accompanied by controls to validate specificity.
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Citrulline Assay NOS convert L-arginine to L-citrulline; therefore, accumulation of L-citrulline was used as a marker of NOS activity and NO production in the past. 145, 146 The main source of citrulline, however, is the urea cycle, and alteration of urea production affects citrulline levels. 147 Furthermore, citrulline is a marker of a wide range of pathologies such as bowel diseases 148 and rheumatoid arthritis. 149 Hence, L-citrulline is not a specific biomarker of NO bioavailability and as such should not be used as an index of NO status.
Recommendations for RNS Measurement
The selection of an assay depends on the experimental conditions and which RNS the investigator wishes to detect. Given the caveats presented above, several assays are available to measure either NO, oxidation products of NO, or other RNS (Figure 2 ). Either EPR with the NO spin trap Fe[DETC] 2 or the fluorescent dye DAF-2 can be used to detect NO with suitable accuracy. Ozone-based chemiluminescence is also quite accurate and can be used to detect not only NO but also nitrite, nitrate, and nitrosothiols. Proper controls, such as inhibition of the NOS enzymes, control for contaminants in the media used, and in some cases, dietary controls for nitrate-rich foods, are essential to yield valid experimental results. For detection of peroxynitrite, no probe or detection method is entirely specific, but when combined with known scavengers of peroxynitrite such as uric acid or BH 4 , oxidation of CM-H or boronate probes can be used. Although peroxynitrite can react with protein tyrosines to form nitrotyrosines, immunostaining for nitrotyrosine is not recommended as a specific signal for peroxynitrite, because nitrotyrosine can also be formed via other pathways. Variations of the Griess assay can be used to detect nitrite, but one needs to be 
Oxidative Modification of Proteins Introduction
Amino acid residues of proteins can act as electron donors, leading to covalent modifications of the amino acid chain. Oxidation of proteins can be induced by many stimuli, including ROS/RNS, metal cations, γ-irradiation, ultraviolet light and ozone, leakage of the electron transport chain in mitochondria, oxidoreductase enzymes, and products of lipid peroxidation. 150, 151 Increased bioavailability of ROS/RNS can lead to protein oxidation in cardiovascular cells. Oxidative modification of proteins has functional consequences such as gain or loss of protein function or enzymatic activity, altered protein-protein interactions, conformational changes, changes in protein localization, susceptibility to proteolysis, increased immunogenicity, and modified gene transcription. Such biochemical modifications alter cell signaling and impair or promote cell functions.
150,152-154
Common Protein Oxidative Modifications in Cardiovascular Cells
Proteins are highly sensitive to posttranslational oxidative modifications, which can be reversible (by biological antioxidant systems) or irreversible. 155 Whereas irreversible modification usually leads to loss of protein function and protein degradation, reversible oxidative modification influences cell signaling and regulatory and homeostatic functions. Most amino acids can be irreversibly modified either directly via oxidation by ROS/RNS or indirectly by secondary by-products of oxidative stress. Some amino acids, such as Cys and methionine (Met), are more susceptible to oxidation than other amino acids because of the nucleophilic nature of sulfur (S) atoms present on their side chains. 156, 157 N-nitrosation of lysine, arginine, and histidine also contributes to protein modification. The most common type of irreversible modification is the formation of carbonyl groups (C=O). Amino acids prone to carbonylation include proline, arginine, threonine, lysine, histidine, and Cys. Assessment of the extent of such generalized oxidation serves as a marker of oxidative stress. 158 Sulfur-containing Cys and Met, the amino acids most susceptible to oxidation, undergo reversible modifications by cellular enzymes and accordingly have a regulatory role in redox signaling. 153 Oxidation of Cys leads to production of sulfenic acid (SOH), which could further react with another Cys residue to form an intermolecular or intramolecular disulfide bond or which could be further oxidized in a stepwise manner to sulfinic acid and sulfonic acid (Figure 3) . 161 Sulfenic acid can be redox recycled back to thiol by the glutaredoxin or thioredoxin systems. 161, 162 Cys sulfinic acids, previously thought to be irreversibly oxidized, can be reduced to the catalytically active thiol by sulfiredoxin. 162 Because Cys is both an e-donor and acceptor, it is considered a redox-active amino acid that plays an important role in the regulation of protein function by ROS in cardiovascular cells.
Met is readily oxidized to form methionine sulfoxide (MetO; Figure 4 ), which can be further oxidized to produce methionine sulfone or radicals. These latter molecules contribute to oxidative damage. 164 Protein methionine oxidation can be reversed enzymatically by methionine sulfoxide reductases. 164 Methionine sulfoxide reductases are repair enzymes that reduce methionine sulfoxide residues in oxidatively injured proteins to methionine residues. Accordingly, these enzymes protect cells from oxidative stress and have been considered as antioxidant and protein repair enzymes. Proteins with oxidation-sensitive methionine residues that are important in the cardiovascular system include calcium/calmodulin-dependent protein kinase II, α 2 -macroglobulin, 15-lipoxygenases, apolipoprotein A-1, thrombomodulin, and von Willebrand factor.
Approaches for Detection of Oxidative Modifications
Protein oxidation can be assessed in cultured cells, circulating cells, and tissue by direct and indirect approaches. Direct approaches detect changes by exploiting the properties of oxidized forms of proteins or structural changes induced by oxidation. Such approaches detect both reversible and irreversible modifications with specific antibodies 165, 166 or chemoselective probes 167 and can be applied at a global or targeted level. Cell-permeable probes have the advantage of labeling within the system, thus preventing any artifactual labeling caused by oxidation on cell lysis. 168 Indirect approaches are most commonly used in cardiovascular research because they exploit conserved biochemical properties of the reversible oxidative modifications, as well as the catalytic activity of certain proteins. Most of these assays are based on the ability of unmodified, active sites (eg, free thiols, S − ) to be irreversibly alkylated and the resistance of oxidized sites (eg, SOH, SNO[S-nitrosothiol]) to alkylation. Indirect approaches monitor reversible modifications by using labeled substrates 169 or probes 170 and can be classified as negative and positive methods. In negative methods, the unmodified sites (eg, S − ) are labeled with the probe, and oxidation is measured as loss of signal. On the other hand, in positive methods, the unmodified sites are alkylated initially, and the reversibly oxidized sites are then reduced and labeled with the probe; therefore, an increase in signal intensity indicates elevated levels of oxidation. Indirect approaches are advantageous because they can provide a relative quantification of the active versus the oxidized state. The major limitation of indirect approaches is that the fraction of reversibly oxidized proteins is overestimated if a significant proportion of oxidized proteins within the sample are in the irreversible state. 171 The sensitivity of these methods can be improved by preparing subcellular enrichments before the assay.
Methods to Assess Protein Oxidation
Irreversible Oxidative Modification: Measurement of Protein Carbonylation (C=O)
The most commonly used direct method to assess carbonylation levels is based on the derivatization of the stable carbonyl groups by 2,4-dinitrophenylhydrazine, which results in the formation of a stable product, dinitrophenyl hydrazone.
e52 Circulation Research August 19, 2016
antibodies has permitted quantification of carbonyl content by ELISA, 174 immunohistochemistry, 175 or Western blotting. 176 Immunodetection by Western blotting offers the advantage of increased specificity compared with all other assays, because it allows for the assessment of carbonylation of individual proteins, which can further be extracted as gel bands and identified by tandem MS (MS/MS). Alternatively, carbonyl groups can be quantified after reduction by sodium borotritide to the corresponding 3 H-radiolabeled hydroxy compound, which is detected by standard methods. 177 An advantage of the methods used for assessment of protein carbonylation is that only standard laboratory equipment is needed.
Reversible Oxidation: Measurement of Cys Thiol Oxidation
Most approaches used to monitor reversible oxidative modifications of Cys thiols rely generally on the efficient trapping of the native redox state of the thiol proteome. For this purpose, all free thiols are selectively alkylated (or trapped) by alkylating agents, such as iodoacetamide and N-ethylmaleimide. 178 Modified Cys residues can be labeled by direct or indirect approaches. The labeled probes used in these strategies can be fluorescently tagged, biotinylated, or isotopic derivatives of thiol alkylating agents. Labeled proteins are typically either separated by 2-dimensional gel electrophoresis and subjected to MS or LC/MS identification in proteomics approaches; pulled down and detected by immunoblotting; or analyzed by Western blotting with specific antibodies, as in the case of a modified cysteinyl-labeling assay. 179 The most commonly used approaches involve alkylation of free thiols with subsequent reduction of the reversibly oxidized thiols and labeling with a probe. Increase in the signal is indicative of elevated oxidation. 170 This approach can assess either global or specific types of reversible thiol modifications, depending on the selectivity of the reductant being used. Dithiothreitol and Tris(2-carboxyethyl)phosphine are considered general reductants and are therefore used for untargeted screening of protein thiol modifications. Detection of sulfenylation, which occurs when free thiols react with H 2 O 2 to form sulfenic acid (R-SOH), is typically based on the specific reduction of sulfenic acid with arsenite. 162 Snitrosylation (RSNO) of free thiols on reaction with NOderived species such as N 2 O 3 (NO + ) or by interaction with Figure 4 . Oxidative posttranslational modifications on methionine residues in proteins. Addition of O 2 to the sulfur atom of methionine (Met) leads to production of methionine sulfoxide (MetO). 163, 164 MetO is reduced back to Met by methioinine sulfoxide reductases. Methionine sulfoxide residues can be further targeted by H 2 O 2 to methionine sulfone, which is an irreversible form of methionine oxidation. 
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The side chain of cysteine residues possess a terminal thiol (-SH) functional group. The sulfur at the core of the thiol is electron rich, allowing multiple oxidation states as shown in the Figure. Protein thiols can form various oxidative modifications, including reversible and irreversible forms. SNO indicates S-nitrosylation; and SOH, S-sulfenylation.
by guest on http://circres.ahajournals.org/ Downloaded from metalloprotein-linked enzymes is another Cys thiol modification that is discussed in more detail below in Modification of Proteins by NO. In addition, formation of mixed disulfides, referred to as S-glutathionylation as a result of other thiol redox reactions can be detected via reduction by glutaredoxin. 162 Although this methodology is widely used, especially during proteomic screenings of the thiol proteome, it does not allow for identification of the specific site of the thiol modification.
A more direct approach in assessing Cys thiol oxidation under nonreducing conditions is the antibody-based strategy. Specific antibodies have been raised to detect S-glutathiolated proteins 180 ; however, their use has limitations because of their low sensitivity. Antibodies have also been generated to react with the hyperoxidized (SO 3 H) form of proteins, such as peroxiredoxin.
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Measurement of Methionine Oxidation
Methionine oxidation is a promising marker of oxidative stress. Conventional methods for assessing MetO generation and reduction depend on HPLC and MS. More recently, novel antibodies and Met-rich proteins have been used to measure methionine/selenomethionine oxidation and methionine sulfoxide reductase.
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Measurement of Sulfenylation
Sulfenylation is typically measured with a specific alkylating agent, 5,5-dimethyl-1,3-cyclohexanedione (dimedone). This approach is based on the principle that sulfenylated proteins react irreversibly with dimedone and can then be isolated by affinity-tagged purification and identified by MS/MS, Western blotting, or fluorescence measurements.
Several dimedone-based probes and antibodies have been developed to provide direct methods for assessment of protein sulfenylation. The probes typically consist of the dimedone reactive group, a linker, and a reporter/affinity tag or an azide group. 183, 184 The tag is usually a fluorophore or biotin, which enables detection of the oxidized proteins with fluorescence. The introduction of an azide group has improved the reactivity of probes (eg, DAz1, DCP-N 3 ), because it allows connection of the bulky reporter/affinity tag to the probe by "click chemistry" after the probe is already bound to the Cys-SOH. 184 Moreover, the recent development of cell-permeable probes (eg, DCP-Rho1, DYn-2) has permitted capture of sulfenylation in living cells, which can be analyzed by confocal or fluorescence imaging. 168, 183 A limitation of using dimedone-based probes is their reduced reactivity with certain protein families, such as protein tyrosine phosphatases, important in signaling in vascular and cardiac cells 185 ; however, this issue has been addressed by generation of dimedone-based probes with a protein tyrosine phosphatase-binding module, which binds irreversibly to the oxidized catalytic site of protein tyrosine phosphatases (eg, BiPhaz-1, NAPhaz-1). 186 In the case of dimedone-specific antibodies, cells need to be treated with dimedone before they are lysed. A limitation of this method is that dimedone reacts irreversibly with SOH groups; therefore, treatment with dimedone for long periods of time will alter the cellular redox state and could generate false-positive results. 187 Another more targeted approach monitors sulfenylation of specific proteins of interest using conformation-specific antibodies, which recognize the oxidized structure of the protein. 188 The limitation of this method is that the crystallographic structure of the unmodified and modified form of the protein has to be known in order for the specific conformation-sensing antibody to be developed.
Most studies examining oxidative modifications of proteins have detected protein S-glutathionylation S-sulfenylation, and S-nitrosylation (see Modification of Proteins by NO). These modifications are increasingly recognized as important signaling events in cardiovascular physiology and disease. The significance of protein S-glutathionylation and S-sulfenylation in cardiovascular disease has been suggested in various experimental models. In rat aortic rings, S-glutathiolated eNOS is associated with impaired vasodilatation. 189 In atherosclerosis, S-glutathionylation induced activation of sarco(endo)plasmic reticulum Ca 2+ ATPase (SERCA) is substituted by irreversible sulfonylation. 190 The cardiac sarcolemmal Na + -K + pump is inhibited by S-glutathionylation on the β1-subunit in ventricular myocytes. 191 In models of ischemia-reperfusion, there is a loss of function of GAPDH, 159 aldose reductase, 192 and actin because of S-glutathionylation 193 Studies that used selective reduction of sulfenic acid and specific probes to assess S-sulfenylation levels have shown that multiple structural and mitochondrial proteins of cardiac myocytes, including cytoskeletal components, undergo sulfenylation after exposure to H 2 O 2 . 194, 195 However, it is still unclear whether sulfenic acids can act as signaling molecules or whether they are intermediates in the process of irreversible oxidation that results in the formation of sulfinic and sulfonic acids.
Modification of Proteins by NO
Nitrosothiols are important mediators of NO signaling pathways 196 and are likely formed by multiple mechanisms, including nitrosation by N 2 O 3 , radical recombination of thiyl radicals with NO, and transition metal-catalyzed reactions. 197 Cellular levels of nitrosothiols can be reduced by denitrosylating enzymes such as S-nitrosoglutathione reductase. 198 The major cellular S-nitrosothiol is S-nitrosoglutathione reductase. 199 An important reaction is transnitrosylation, in which NO is transferred from one thiol to another. 200 Several methods have been developed for detection of protein and low-molecular-weight nitrosothiols; however, these techniques are challenging and prone to artifacts. 201 These measurements can be affected by light, reducing agents, and pH because of an effect on nitrosothiol stability. Chung et al 202 offer a comprehensive review on the utility of Cys tandem mass tag (cysTMT) to detect and determine the reactivity of an individual Cys's reactivity for S-nitrosylation. This approach has facilitated the identification and quantification of Cys oxidative modifications in cardiovascular cells and tissue. 202 Other major methods of nitrosothiol detection include chemiluminescence-based methods and switch-based methods, 201 and recently, nitrosothiol-specific antibodies have been developed. 203, 204 The biotin-switch method of detecting nitrosothiols is similar to that described in Reversible Oxidation: Measurement of Cys Thiol Oxidation. For measurement of nitrosothiols, this method consists of 4 major steps: (1) thiol blocking, (2) selective reduction of RSNO, (3) labeling of resultant free thiols, and (4) detection of biotin-labeled thiols. 201 Significant concerns have arisen regarding the potential artifacts associated with high levels of ascorbate that can potentially reduce some protein disulfides. 205 Phosphine-mediated selective reduction appears to be preferable because it is specific for nitrosothiols and does not reduce protein disulfides. 206 Both polyclonal and monoclonal antibodies have been developed that can detect RSNO moieties. 203, 204, 207 An example is the anti-S-nitrosocysteine antibody, which detects S-nitrosocysteines but not reduced cysteines. 203 It is generally recommended that one use positive and negative controls with chemical nitrosation and cleaving of S-NO bonds in situ. 208 If cleaving the S-NO bonds does not reduce the signal, then immunostaining is likely nonspecific.
A third method of detecting NO-mediated protein modification is anaerobic reductive chemiluminescence, which uses excess Cys to drive the transnitrosation equilibrium in favor of CySS-NO and reduce Cu 2+ to Cu + . Reductive RSNO assays are performed under helium or argon in a purge vessel that contains Cys and CuCl. 201, 208 The free NO that is released is purged in the inert gas stream to a chemiluminescence-based NO analyzer. Photolysis-chemiluminescence is based on photosensitive homolytic cleavage of RSNO after exposure to light; however, ultraviolet photolysis has been criticized for overestimating RSNO values because of the presence of endogenous nitrite and nitrate that can also be converted to NO by ultraviolet irradiation. 209 The Cu-Cys assay is not useful for solutions with high protein content (plasma, hemoglobin) and has been replaced by triodiode (KI 3 )-based reductive chemiluminescence, which provides a more specific assay of RSNO levels. 210, 211 Triodiode-based assays have become the most accepted and widely used method for RSNO measurement, providing sensitive and specific measurements in complex systems.
A cardioprotective role of S-nitrosylation has been demonstrated for cyclooxygenase 2 212 and mitochondria complex I, 213 translated as attenuated infarct size during ischemia-reperfusion. In rat hypoxic myocardium, decreased S-nitrosylation of Na + -K + ATPase was followed by increased S-glutathionylation and loss of activity. 214 S-nitrosylation of p47phox by NO has been shown to suppress Nox-induced ROS production in human endothelial cells. 215 On the other hand, impaired relaxation in mouse aorta has been related to protein kinase C S-nitrosylation, 216 as well as to augmented global S-nitrosylation in Ang II-induced hypertension. 217 Studies in bovine aortic endothelial cells demonstrated increased levels of S-nitrosylated endothelial NOS, which was reduced on stimulation with vascular endothelial growth factor.
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Measurement of Protein-Derived Radicals
Immuno-spin trapping with anti-DMPO antibodies is a useful approach for detecting protein-derived radical intermediates both in vitro and in vivo. Antibodies produced in rabbits immunized against the hapten 5,5-dimethyl-2-octanoic acid-1-pyrroline N-oxide (OA-DMPO, a structural analog of DMPO with an additional carbon chain terminating in a carboxylgroup for amide linking) bind specifically to the protein adduct of DMPO. [219] [220] [221] This approach expands the utility of spin trapping without EPR and can be highly sensitive in detecting protein radicals formed under physiological or pathological conditions. It can be used in conjunction with immunoblotting analysis, immunofluorescent staining, flow cytometry, and even magnetic resonance imaging. In combination with MS, immuno-spin trapping has been used to define the role of protein thiol radicals in mediating S-glutathionylation of mitochondrial complex I at the level of isolated enzymes, myocytes, and hearts of eNOS −/− mice. 13, 30, 222 In endothelial cells, the same approach has been used to examine a similar mechanism in regulating protein S-glutathionylation coupling, and function of eNOS. 223 Anti-DMPO antibodies can also be covalently bound to an albumin-gadolinium-diethylenetriaminepentaacetic acid-biotin magnetic resonance imaging contrast agent and used for molecular magnetic resonance imaging. 224, 225 This approach has been used to detect in vivo levels of membrane-bound protein/lipid radicals in kidney, liver, and lung of diabetic mice. 225 Immuno-spin trapping is a unique and powerful approach to detect protein radical intermediates in time and space; however, the approach is limited to the specific protein radical adducts of DMPO, mainly Cys-and tyrosine-based protein radicals. Additional antibodies against different type of spin traps (eg, nitroso spin traps) could provide broader utility in determining other types of protein radicals.
Tyrosine or Tryptophan Modifications
Tyrosine and tryptophan nitration are common posttranslational modifications that affect protein structure and function. 3-Nitrotyrosine and nitrotryptophan are formed on reaction of OONO − with proteins containing tyrosine or tryptophan residues. Alternatively, these modifications can occur by peroxidase-mediated reactions between protein tyrosines or tryptophans and nitrite. Such changes have been detected by MS and immunostaining in various disease processes, including aging. 226, 227 They have also been used to serve as a footprint of peroxynitrite formation in vivo 228 ; however, peroxidase-based reactions of nitrite with tyrosines can also yield nitrotyrosine and in fact might be its major source in vivo. HPLC, biotin tagging, MS/MS, and immunological methods have been used for nitrotyrosine and nitrotryptophan detection. 144, 229 MS/MSbased peptide sequencing provides unambiguous confirmation of nitrotyrosine formation. Antibodies purported to detect nitrotyrosine also detect nitrotryptophan, 230 and so must be used with caution.
Formation of dityrosine residues as a result of oxidative damage has also been used as a marker of oxidant stress. In this method, dityrosines are first released by acid hydrolysis in antioxidant-containing buffers and then derivatized with heptafluorobutyric anhydride/ethyl acetate before analysis by MS. This method can be used on whole tissue, but usually dityrosine formation on individual proteins is below the detection limit of the assay.
Recommendations for Measurement
Considering the importance of oxidative stress and redox signaling in cardiovascular pathophysiology, unraveling exactly how protein function is changed by oxidation is critical to elucidate molecular mechanisms of disease. Accordingly assessment of oxidative modifications of proteins, a posttranslational by guest on http://circres.ahajournals.org/ Downloaded from phenomenon, should be a priority in the tool kit of redox methodologies in cardiovascular research.
Although MS-and electrophoresis-based proteomics are commonly used, these approaches separate proteins as individual polypeptides rather than as functional complexes. Moreover, data generated are rarely quantitative and do not indicate modification levels per functional unit, and full resolution of basic or hydrophobic proteins, including membrane-associated proteins, cannot be attained with current technology. Hence, these techniques provide information on global oxidative changes. Another system that is gaining popularity in cardiovascular research is the OxyBlot (Merck Millipore) protein oxidation assay, which is ideal for rapid detection of proteins modified by ROS. This assay, which can be performed in crude or purified protein preparation, measures carbonyl groups introduced into protein side chains and also gives an assessment of global rather than specific protein oxidation.
In-depth characterization and quantification of oxidative modification of individual proteins requires complex oxidative proteomics. Such studies should be performed in collaboration with specialized proteomics laboratories. However, it is becoming relatively simple to detect individual oxidized proteins within a mixture of proteins using immune-based techniques, such as Western blotting, ELISA, and immunohistochemistry/immunocytochemistry. Numerous commercial antibodies to assess nitrosylation, glutathionylation, carbonylation, and sulfenation of proteins are now available, which makes assessment of protein oxidation in cardiovascular cells and tissues relatively simple. Immunostaining can also be used to measure 3-nitrotyrosine, a marker of RNS. Other immune-based methods rely on 5-iodoacetamido fluorescein to label oxidized sulfhydryl groups, which can then be pulled down with fluorescein antibody. 154 Alternatively, proteins such as thioredoxin can be derivatized at the active-site Cys thiols using a large maleimide derivative, and then nonreducing gel electrophoresis can be used to separate reduced (labeled) and oxidized (unlabeled) proteins based on their size. 231 Choice of method depends on the availability of species-specific antibodies, the type of modification to be studied, and the particular protein of interest. As with other redox methods, appropriate controls must be included to demonstrate specificity of the protein modification under study.
Measurement of Lipid Peroxidation Introduction
Because of their highly reactive state, ROS are unable to diffuse away from their site of formation, which often leads to only site-specific alterations. Thus, it has been suggested that lipid peroxidation products amplify and propagate the cellular effects of ROS. 232, 233 Measurements of lipid peroxidation products are therefore not only sensitive assessments of ROS generation but also provide mechanistic insights into the pathogenesis of ROS-induced injury.
Common Lipid Oxidative Modifications
Oxidation of lipids (peroxidation when biological material is involved) is a complex process, with several free radicals, metastable intermediates, and end products. 234, 235 Several products of lipid peroxidation can be measured to document ROS-mediated lipid peroxidation in biological tissue. Because of their extremely short half-life, C-centered radicals or peroxyl radicals are rarely measured, except in detailed mechanistic studies.
Measurement of Lipid Peroxidation
Lipid Hydroperoxides
Lipid hydroperoxides (LOOH) are usually measured by HPLC, because they are largely degraded during MS. Older methods for LOOH separation/detection used either chemiluminescence 236 or mercury cathode electrochemical detection. 237 These methods have been improved considerably by the inclusion of appropriate stable isotope internal standards 238, 239 and are suitable for the measurement of LOOH in plasma, lowdensity lipoprotein, and tissue samples. Phospholipid LOOH in tissues and cells can also be identified by HPLC followed by fluorescence detection. 240 The method has high sensitivity (1-2 pmol of LOOH), although its specificity remains unclear. The formation of specific hydroperoxides can be used to study the reactivity of specific ROS; for instance, singlet oxygen, ozone, or ionizing radiation in biological tissues can be specifically documented by measuring specific cholesterol hydroperoxides.
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Unsaturated Aldehydes
Aldehydes such as 4-hydroxy-trans-2-nonenal (HNE), malondialdehyde (MDA), isoprostanes, and acrolein are major end products of lipid peroxidation. 232 Among the free aldehydes generated from lipid peroxidation, the C9 unsaturated aldehyde HNE is the most abundant product of arachidonic acid 241 and is one of the most studied products of lipid peroxidation. Tissue and plasma concentrations of free lipid peroxidation-derived aldehydes such as HNE can be measured by HPLC or gas chromatography (GC)/MS. HPLC methods usually use aldehyde-reactive probes such as 2,4-dinitrophenylhydrazine and 1,3-cyclohexandione or other similar chemical probes. 242 Derivatization by reagents such as pentafluorobenzyl oxime followed by silylation is also required for detection with negative chemical ionization by GC/MS. 243, 244 With the use of an appropriate deuterated internal standard, GC/MS can be a sensitive and reliable method for the measurement of free HNE 245, 246 ; however, current approaches that use LC/MS 247, 248 are preferable because they do not require derivatization to enhance optical activity or to generate a volatile product. In addition, measurement of HNE-modified proteins has been widely used as a measure of oxidative stress and ROS generation in a variety of disease conditions, and coupled with MS identification of the modified proteins, [249] [250] [251] it can provide mechanistic understanding of oxidative stress-induced injury and dysfunction.
Proteins antibodies raised against HNE-treated keyhole limpet haemocyanin 252, 253 or bovine serum albumin 254 have been used to identify HNE-histidine adducts, with little cross-reactivity with HNE-lys or HNE-cys.
Increased formation of HNE and related aldehydes such as acrolein in animal models and humans can also be measured by quantification of their urinary metabolites. The major urinary metabolites are mercapturic acid derivatives. In mouse and rat urine, the most abundant HNE metabolite is 1,4-dihydroxynonane-mercapturic acid (DHN-MA), 255, 256 which is derived from the reduction of the glutathione conjugate of HNE (GS-HNE) to GS-DHN by the enzyme aldose reductase. 257 Similarly, the reduced form of the mercapturate derivative (3-hydroxypropanal mercapturic acid; 3-HPMA) is also the most abundant urinary metabolite of acrolein in rats. 258 Both DHN-MA 255,259 and 3-HPMA 260,261 have also been detected in human urine and have been linked to oxidative stress; however, because in addition to lipid peroxidation acrolein can also be derived from exposure to combustion products and cigarette smoke, DHN-MA might be a more selective marker of lipid peroxidation than 3-HPMA in humans.
Oxidized Phospholipids
In addition to free aldehydes, peroxidation of phospholipids generates carbonyls that remain esterified to the phospholipid backbone. The most commonly studied oxidized phospholipids are 1-palmitoyl-2-oxo-valeroyl-sn-glycero-phosphocholine (POVPC), 1-palmitoyl-2-glutaroyl-sn-glycero-phosphocholine (PGPC), and 1-palmitoyl-2-(5,6-epoxyisopro-stane E2)-snglycero-phosphocholine (PEIPC). 262, 263 These phospholipids are derived from the oxidation of 1-palmitoyl-2-arachidonylglycerol-3-phosphocholine (PAPC), one of the most abundant phospholipids in low-density lipoprotein. The levels of these oxidized phospholipids can be measured by electrospray ionization MS in tissues after chloroform-methanol extraction and solid-phase extraction chromatography using dimyristoylphosphatidylcholine as an internal standard. 262 Such measurements have shown that aortas obtained from rabbits fed an atherogenic diet contain higher levels of POVPC, PGPC, and PEIPC than those from rabbits fed a control diet. 262 Moreover, oxidation products of cardiolipin, which is abundant in the mitochondria, can be measured as specific biomarkers of mitochondrial oxidative stress with LC/MS. 264 Because oxidation creates new epitopes, oxidized phospholipids are recognized by antibodies of innate immunity. Several natural monoclonal IgM antibodies have been cloned, including E06, [265] [266] [267] which was cloned from apolipoprotein E-null mice. 268 These IgM autoantibodies have been shown to identify oxidized phospholipids in arterial plaques 268 and in lipoproteins, although the specific epitopes recognized by these antibodies have not been well-defined because they also recognize MDA-modified low-density lipoprotein or high-density lipoprotein, which suggests that they recognize the adduct between oxidized lipids and apoproteins. 268 Of these antibodies, E06 appears to specifically recognize the perturbed phosphorylcholine headgroup of oxidized phospholipids and can be used to recognize these phospholipids in cells, tissues, and lipoproteins. Therefore, positive reactivity to the antibody can be a useful indicator of the oxidation of phosphocholine phospholipids in cells and tissues. However, in most cells, oxidized phospholipids are readily removed, either by cytosolic enzymes with phospholipase A2 activity, which removes the oxidized sn-2 side chain, 269 or by the reduction of sn-2 aldehydes by aldose reductase. 270 Hence, the absence of oxidized phospholipids does not necessarily indicate a lack of lipid peroxidation, and the measured levels are reflective of a steady state achieved between the generation and the metabolism of these phospholipids.
Oxidized phospholipids can also be measured in the plasma, and the levels of oxidized phospholipids bound to lipoproteins correlate with the extent of angiographically documented atherosclerotic disease, 266 which suggests that oxidized phospholipid might be involved in the formation of atherosclerotic lesions.
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Isoprostanes
Nonenzymatic peroxidation of arachidonic acid generates prostaglandin-like compounds that have been measured as reliable biomarkers of oxidative stress in general and lipid peroxidation in particular. Several chemically distinct species of isoprostanes are generated from the oxidation of arachidonic acid.
272,273 From 4 F 2 -isoprostane (IsoP) regioisomers, each composed of 8 racemic diastereomers, 64 different species are generated. Although oxidation products of arachidonic acid have been classically measured as markers of lipid peroxidation, other isoprostanes derived from eicosapentaenoic acid, docosahexaenoic acid, adrenic acid, and α-linolenic acid provide a more comprehensive picture of fatty acid-specific lipid peroxidation. 274 In principle, any or all of these isoprostanes could be measured; however, practically, only a few of these species are quantified, of which the 5-series F 2 -IsoPs and the 15-series F 2 -IsoPs derived from arachidonic acid are most frequently measured.
Because of the high structural diversity of isoprostanes, GC/MS or LC/MS is the method of choice for measuring these species, although ELISA-based immunoassays are also used frequently. The immunoassays, although simpler, cheaper, and faster, have high variability. There is poor correlation between different immunoassays, and the values obtained from ELISA often do not correspond to those measured by GC or LC/MS. 275 Moreover, the antibodies used in these assays exhibit cross-reactivity with molecules of related structure, such as the products of cyclooxygenase. 276 Immunoassays are also highly sensitive to interference by biological impurities present in complex biological systems, such as cell extracts, urine, or blood. Hence, the results obtained from ELISA and other immunoassays should be interpreted with caution. The most sensitive and accurate measurements of isoprostanes involve quantification by GC/MS with appropriate deuterium-labeled internal standards. 277, 278 These methods can measure isoprostanes to a lower limit of quantification of 2 to 100 pg/ml and can be optimized to measure multiple species of isoprostanes and isofurans. 277 However, these techniques require elaborate sample preparation steps, such as thin-layer chromatography, solid-phase extraction, liquid-liquid extraction, or affinity chromatography. Moreover, the samples must undergo chemical derivatization to pentafluorobenzyl ester, trimethylsilyl ether analogs before GC/MS. As a result, only a few specialized laboratories have the necessary experience and infrastructure to reliably measure isoprostanes by GC/MS.
In contrast with the GC/MS methods, LC/MS measurements of isoprostanes require shorter procedures for sample preparation, with no derivatization step. Although earlier methods suffered from poor resolution, long run times, and low sensitivity, newer methods using ultraperformance LC with tandem MS detection using multiple reaction monitoring rival or exceed the sensitivity and specificity of GC/MS techniques.
279, 280 These methods generate high resolution of analytes to minimize matrix effects 281 and can measure isoprostanes in the low picomolar range. With such high-sensitivity methods, changes in the levels of 15-F 2 -IsoP can be measured in as few as 10 000 cells. 280 These methods can also be adapted to simultaneously measure both enzymatically and nonenzymatically generated eicosanoids. 282 Although these techniques require sophisticated mass spectrometers and ultraperformance LC, they enable rapid, accurate, and sensitive detection of a wider range of isoprostanes and related species than has been possible thus far.
Isoprostanes are more stable than other products of lipid peroxidation and are therefore measured as reliable indices of oxidative stress. Levels of F 2 -IsoP in blood and urine have been measured to assess systemic oxidative stress in both animals 283 and humans 284 under conditions of validated oxidative stress and in animal models of atherosclerosis, transplant arteriosclerosis, flow-induced vascular remodeling, 285 and age-accelerated atherosclerosis. 286 Additionally, urinary levels of isoprostanes have been used to document an increase in oxidative stress in humans with high cardiovascular disease risk, 287 diabetes mellitus, 288 or pulmonary hypertension 289 and to document increased free radical generation after reperfusion in patients undergoing acute coronary angioplasty. 290, 291 In the plasma, F 2 -IsoPs circulate in their free unesterified form, although they can also be bound to the phospholipid backbone, from which they can be released by platelet-activating factor acetylhydrolase. Because the levels of free and bound isoprostanes are highly correlated, usually only levels of free isoprostanes are measured. The metabolism of F 2 -IsoPs in the liver generates multiple metabolites, including those generated by their conjugation with taurine or glucuronide. In human studies, these metabolites are measured along with the unmetabolized parent compound.
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Recommendations for Measurement
In the design of experiments, the choice of the lipid peroxidation product to be measured will depend on the overall objective of the study ( Figure 5) ; however, in general, measurement of lipid peroxidation products can provide a useful and informative index of oxidative stress. Direct measurements of lipid peroxidation products such as HNE, acrolein, or lipid hydroperoxides, however, are difficult because they are rapidly metabolized or react readily with other cell constituents. Therefore, the formation of these products is usually assessed indirectly by measuring their covalent protein adducts. Measurements of protein-HNE or protein-MDA adducts provide unambiguous evidence for lipid peroxidation, Figure 5 . Analytical methods for measuring products of lipid peroxidation in experimental and clinical studies. The choice of the assay depends on the experimental system. Assays suitable for different experimental systems are shown in horizontal bars. Measurements of conjugated dienes are suitable only for isolated membranes and cells, whereas thiobarbituric acid reactive substances (TBARS), free 4-hydroxy-trans-2-nonenal (HNE) and malonaldehyde (MDA) levels, hydroperoxides, isoprostanes, oxidized lipids, and protein-aldehyde adducts can be measured in most experimental systems. Autoantibodies against protein conjugates of aldehydes can be measured in the animal and human plasma, whereas urinary isoprostanes and metabolites of aldehydes (mercapurates) can be measured in the urine. Assays listed as primary (1°) are the most well accepted, secondary (2°) are more widely used, and tertiary (3°) are either less sensitive or less specific (TBARS) or should be verified with a second method. and an increase in abundance of these adducts is likely to be reflective of increased oxidative stress. However, these assays, although qualitative, are not very quantitative. When generated, HNE and MDA react with multiple proteins that show variable levels of modification, making quantification of the total extent of lipid peroxidation somewhat challenging. Moreover, some proteins are adducted to HNE or MDA at baseline, and therefore their presence interferes with quantification of the total adduct formation. In addition, proteins covalently modified by HNE are readily degraded by proteolysis, 292 and thus, measurements of the levels of these adducts at a single time point could underestimate their formation. Hence, it is preferable to measure more stable products of lipid peroxidation, such as isoprostanes, in urine, blood, or tissue if the intent is to document total local or systemic oxidative stress. F 2 -IsoPs have been well validated as markers of oxidative stress both in animal and clinical studies. 273 Nevertheless, measurements of specific products of lipid peroxidation such as lipid hydroperoxides, protein-HNE adducts, or oxidized phospholipids are useful in addressing specific mechanistic questions.
Oxidative Modification of DNA Introduction
One of the more severe consequences of excessive ROS production is oxidative modification of DNA. 293 Characteristic DNA modification has been detected under several pathological conditions associated with increased oxidative stress; however, whether these modifications contribute to disease progression or are a consequence of pathologically increased ROS levels remains to be determined. 294 Techniques to measure DNA oxidation can be applied to both nuclear and mitochondrial DNA, and many are applicable to RNA, which also undergoes oxidative modification. 295 Oxidation of guanine has been considered to be a surrogate measure of oxidative DNA modification, but there are several other chemical modifications of DNA that are induced by ROS and RNS, including (1) purine and pyrimidine base lesions generated by oxidation, deamination, depurination, and depyrimidination; (2) modification of the sugar moiety; (3) formation of protein-DNA cross-links; (4) formation of DNA-DNA cross links; and (5) single-and double-strand breaks. 296 Typically, strand breaks occur when a base is oxidized, for instance, conversion of guanosine to 8-hydroxy-deoxyguanosine, on which endogenous enzymes excise the modified base, creating an abasic site. Sometimes, the newly added base is a mismatch, which can lead to errors in replication. Modification of the sugar moiety by ROS such the alkoxyl radical generates reactive aldehydes such as base propenals and MDA. 297 These aldehydes, generated from radical oxidation of 2-deoxyribose, like those generated from lipid peroxidation, react with nucleophilic centers in the DNA and modify DNA bases. In aggregate, between 50 and 75 base modifications have been reported, although to date, some of these have been found only under in vitro conditions in which oxidative modification was specifically induced. 293, 294, 298 Under normal conditions, there appears to be a background level of ROS-induced damage in both nuclear and mitochondrial DNA that is normally repaired by enzymes such as the DNA glycosylases. These repair mechanisms can be broadly summarized as base excision repair, nucleotide excision repair, and mismatch repair. Although estimates of DNA damage range from 100 000 to 1 000 000 lesions per genome per cell division, 299 the overall rate in humans appears to be about 1 mutation per 30 million base pairs per cell generation.
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Mechanisms of Oxidative Damage to Nucleotides
Although several ROS can modify proteins, their reactivity with DNA is more limited. Some species such as the • OH radicals and crypto-OH or ferryl-OH react avidly with DNA, whereas other species such as O 2 . − or H 2 O 2 are not known to directly modify DNA. 298, 301 Additionally, RNS such as OONO − can react directly with DNA. 302 In vitro, the • OH radical reacts with DNA by addition to double bonds of DNA bases and by abstraction of an H atom (also known as hydrogen atom transfer) from the methyl group of thymine and the C-H bonds of 2′-deoxyribose. The
• OH radical also reacts with carbons at the C5-C6 double bond of pyrimidines, which results in the production of C5-OH and C6-OH adduct radicals. Hydrogen atom transfer from thymine results in the allyl radical. Adduct radicals differ in terms of their redox properties, with some being reducing (C5-OH) whereas others are oxidizing (C6-OH). 298 These radicals can form many different products (see references 294, 296, and 298 for detailed lists of the many products) depending on their redox properties and environment (eg, presence or absence of oxygen or reaction partners), but for the purposes of this statement, we will focus on the measurement of oxidation modification in broad categories: chemical modification, fragmentation, and abasic sites.
Measurement of DNA Damage
Oxidative DNA base damage is measured by either direct or indirect approaches. 303 Direct approaches use sophisticated analytical procedures, for example, MS, to evaluate chemical modification of extracted and purified DNA. Indirect approaches involve the use of a specific DNA repair enzyme and measurement of DNA strand breaks. For indirect analysis, a DNA N-glycosylase repair enzyme is used to excise the modified bases, which induces a strand break that can be measured by reliable methods such as the comet assay and the alkaline elution technique. More recent techniques use polymerase chain reaction (PCR) to evaluate strand breaks in mitochondrial DNA or antibodies directed against oxidized bases to quantify base modification.
Among DNA bases, guanine has the lowest ionization potential, which makes it more nucleophilic and therefore more susceptible to oxidation than other bases. 296 For this reason, some assays have focused specifically on the oxidation of guanine, or 8-oxoguanine; however, a caveat for these measurements is that sometimes the nature of the procedure affects the measurements. For instance, LC or LC/MS techniques can potentially overestimate 8-oxoguanine levels in the sample because of spontaneous oxidation of the guanine during sample preparation. 304 Hence, it is imperative that all methods of by guest on http://circres.ahajournals.org/
Downloaded from
Griendling et al
Measurement of Reactive Oxygen Species e59
procedure are performed with extreme care to avoid spurious oxidation during sample preparation.
Comet Assay
The comet assay is a simple method based on gel electrophoresis that enables measurement of DNA strand breaks in cells. 305 Isolated cells are mixed with an agarose solution, which is then allowed to gel. The imbedded cells are then lysed and electrophoresed at an alkaline pH, which produces comet-like structures when the DNA is observed by fluorescence microscopy. The "intensity" of the fluorescent signal of the comet tail relative to the head reflects the number of DNA breaks. 306 The comet assay has been used to evaluate DNA strand breaks in cardiac myocytes subjected to oxidative injury. 307 Although this assay is simple and easy to use, it provides only general information about strand breaks and does not provide insight into the nature of the oxidative modification.
Mass Spectrometry
Typically, MS analysis of ROS-induced DNA damage involves GC-MS, HPLC-MS, or electrospray ionization MS analysis. 308, 309 MS can detect a range of specific oxidations of DNA bases, including 8-oxoguanine, thymidine hydroperoxides, and oxidizing or reducing radicals. Although MS is highly sensitive (femtomolar range), the approach is not without limitations. For example, conditions of sample preparation (derivatization of the nucleotides) for GC-MS are conducive to oxidation and can lead to overestimates of the amount of oxidized DNA. Therefore, for GC-MS analysis of ROS-induced DNA modification, it is important to incorporate procedures to prevent excessive sample oxidation, such as the addition of antioxidants. Other MS methods, HPLC-MS and electrospray ionization MS, are less prone to induce sample oxidation, and these approaches also allow precise identification of the nature of the chemical modifications. MS has been used to study oxidative and DNA damage in experimental models of cardiovascular disease. For example, in Ang II-induced hypertension in mice, O 2 . − formation, double-strand DNA breaks, and mutagenic DNA base modification 7,8-dihydro-8-oxoguanine were increased in the heart and kidney, effects that were attenuated by TEMPOL treatment. 310 Similarly, Daehn et al 311 described 8-oxoguanosine accumulation and evidence for DNA fragmentation linked to endothelial dysfunction in glomerulosclerosis.
High-Pressure Liquid Chromatography
HPLC coupled to electrochemical detection is another useful technique for measuring oxidatively modified DNA. 309 It is a fairly sensitive technique and is also relatively inexpensive to use; however, it is not as sensitive as the LC/MS methods and does not enable identification of the molecular modification of the base.
Immunoassays
The use of antibodies that recognize 8-oxoguanine is another useful technique for analyzing oxidatively modified guanine. 312, 313 This approach has been used to "visualize" the base lesions with immunostaining or to provide a more comprehensive view of the modifications via Western blotting. For example, Martinet et al 314 showed elevated 8-oxo-guanine in rabbit atherosclerotic plaques, and Mayr et al 315 used anti-8-oxoguanine antibodies to detect DNA damage in vascular smooth muscle cells exposed to mechanical stress. An ELISA can also be performed to quantify these modifications with a high-throughput plate reader approach. The caveats to this approach are similar to any measurements that use antibodybased analytical approaches; namely, that it is imperative to establish the specificity of the antibody because methods reported in the literature often use different concentrations of primary and secondary antibodies and different blocking agents. Also, the use of a secondary antibody in the absence of the primary antibody serves as an important control in immunostaining approaches to determine background or nonspecific staining. The principal advantage of this technique is that the use of antibody-based analyses is routine in many laboratories, and hence, these techniques can be readily extended to oxidatively modified DNA. The limitations are that only 1 base modification is analyzed, and as mentioned above, sometimes the sample preparation induces oxidative modification of guanine; thus, these measurements could overestimate the amount of injury that is occurring in a cell or tissue. Another limitation is that some antibodies raised against 8-oxoguanine cross-react with guanine, which would overestimate the number of oxidized bases. 316, 317 Hence, this approach is better suited for qualitative rather than quantitative analysis of DNA damage.
Southern Blotting
Oxidative damage to DNA can also be assessed by Southern blotting, [318] [319] [320] and this can be applied to nuclear or mitochondrial DNA. For this procedure, known amounts of isolated DNA are incubated in sodium hydroxide to produce single-strand breaks at abasic sites present in the DNA because of repair of oxidatively modified bases. This mixture is electrophoresed and transferred to a nylon membrane, where it is hybridized with a 32 P-labeled probe for DNA sequencing. The break frequency can be derived from the band intensity of the oxidatively modified DNA as a function of the intensity of the control DNA bands. An advantage of this technique is that there is no requirement for expensive, high-end equipment; only routine electrophoresis equipment, commonly available in most laboratories, is needed. The disadvantages are that the exact nature of the base lesion or lesions is not revealed and that the site where the lesion occurs cannot be identified.
Polymerase Chain Reaction
Several approaches have been adopted to evaluate oxidative DNA modification with PCR. [321] [322] [323] One such approach involves the treatment of DNA with formamidopyrimidine glycosylase to produce strand cleavage at sites of oxidized purines, thus creating single-strand breaks that block PCR amplification. The difference in PCR amplification between formamidopyrimidine glycosylase-treated and untreated DNA is then used as an estimate of oxidative base damage. Data can be expressed as the change in lesion frequency normalized to a 1-kb sequence, calculated from the quotient of band intensities in the formamidopyrimidine glycosylase-treated and untreated samples. Another PCR strategy involves determining the concentration of different sized PCR products (0.2, 2.9, and 16 kb) amplified from mitochondrial DNA. 324 If there are no lesions, the products should all have the same concentration, but if there are lesions, there will be less concentration of the larger products than the smaller ones. Using this approach, DNA lesion frequencies (break points in DNA) are calculated as the amplification of damaged (treated) samples relative to the amplification of nondamaged controls (from genomic DNA), which results in a relative amplification ratio (treated/control). The principal advantage of the PCR approach is the relative ease of the assay; a disadvantage is that the specific nature of the base lesion is not known, nor is the identity of the nucleotide revealed by this approach. Wosniak et al 325 used this method to assess mitochondrial DNA damage in rabbit vascular smooth muscle cells exposed to Ang II.
Recommendations for Measurement
A variety of techniques can be used to assess oxidative DNA base damage, but the choice of the method depends on the nature of the research question ( Figure 6 ). If the question pertains to the formation of a particular sugar or base modification, then an approach using MS is more informative. If instead the question pertains to general base modifications, then a less precise technique might be applicable. The most important aspect of application of these techniques is careful preparation of the sample, as oxidation of bases during the analysis procedures overestimates oxidative modification of DNA and RNA. We refer the reader to Collins et al (Table I) , 326 in which oxidation of guanine was evaluated by a number of methods, with a range of nearly 4 orders of magnitude. This variation is in part attributable to the method used and to the sample preparation. Thus, no matter which technique is used to determine the oxidative modification of DNA or RNA by ROS, the measurements are only as good as the care and preparation of the samples. This is likely the most critical and overlooked aspect of these measurements. As a general measure of DNA damage, the comet assay or immunoassays for 8-oxoguanine can be used; alternatively, HPLC-based approaches represent a sensitive and economical alternative. However, for more detailed analysis and for identification and quantification of DNA oxidation, MS-based approaches (GC-MS, HPLC-MS, or electrospray ionization MS) are recommended.
Measuring ROS and RNS and Oxidative Stress in Clinical/Translational Studies
On the basis of preclinical studies showing that ROS/RNSinduced oxidative stress plays a key role in cardiovascular physiology and pathology, measurements of these species and oxidative stress should be useful in understanding cardiovascular function and disease in humans. However, because free radicals and other ROS/RNS are very reactive, they are difficult to measure. As a result, accurate measurements of ROS/RNS such as O 2 . − , H 2 O 2 , or NO in human tissues and biological fluids is challenging. Hence, indirect methods that involve the measurement of stable end products or biomarkers of oxidative stress have been used to assess oxidative status in clinical and translational studies. Although several circulating biomarkers are currently used to assess oxidative stress in humans, an ideal biomarker, as defined by Giustarini et al 327 (Table 3) , has not yet been identified. Therefore, in human studies, measurements of multiple independent indices of oxidative stress are recommended. Several such biomarkers are currently being measured, primarily in research laboratories, but are not yet routine assays in clinical laboratories because their diagnostic value remains uncertain.
Lipid Peroxidation
Because of their relatively high stability, products of lipid peroxidation in blood and urine are frequently measured to assess oxidative stress in clinical and translational studies, including lipid hydroperoxides, MDA, F 2 -IsoPs, and HNE.
Lipid Hydroperoxides
Several clinical studies have used LOOH as an index of peroxidative injury of membrane lipids and oxidative stress. 328, 329 Such studies have shown that plasma levels of lipid hydroperoxides are higher in patients with ischemic heart disease, peripheral artery disease, 330 heart failure, 331 and type 1 diabetes mellitus. 332 Increased levels of lipid hydroperoxides have also been detected in the venous effluent of reperfused myocardium 333 and in the plasma after thrombolytic therapy, 334 which indicates that measurements of lipid hydroperoxide can be a reliable index of acute oxidative stress. Changes in plasma levels of lipid peroxides have also been measured to document changes in oxidative stress after drug intervention. 335 In PREVENT (Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial), baseline serum LOOH levels, measured by the ferrous oxidation of xylenol orange (FOX) assay, were found to correlate with thiobarbituric reactive substances (TBARS) and with higher risk of vascular events. 336 Overall, measurements of plasma LOOH levels are a useful index of oxidative stress, although it is unclear whether this is reflective of systemic oxidative stress or local oxidation of circulating lipoproteins.
Malondialdehyde
MDA is a stable end product of lipid peroxidation and can be measured as an index of oxidative stress; however, few studies measure MDA directly but instead rely on measurement of TBARS in the plasma. It has been reported that plasma TBARS levels are increased in patients with coronary artery disease, hypertension, atherosclerosis, diabetes mellitus, heart failure, stroke, and aging. [337] [338] [339] [340] [341] Cigarette smoking is also associated with elevated levels of TBARS, which suggests that proatherogenic and vascular injury effects of smoking might be related to oxidative damage induced by lipid peroxidation. 342 Some studies have shown that plasma TBARS can predict cardiovascular events. For example, it has been reported that elevated plasma TBARS predict carotid atherosclerotic plaque progression over a 3-year period, as validated by carotid wall thickness measured with ultrasound. 343 In the PREVENT trial, patients with high TBARS levels at baseline were at increased risk of vascular events. 336 The vascular risk reflected by TBARS was found to be independent of C-reactive protein, interleukin 6, and traditional risk factors. 336 Of the oxidative stress biomarkers used clinically, plasma TBARS is among the most common; however, because of the nonspecificity of the test, it is not clear which specific species are being measured, and there is a high probability of increased artifactual generation of TBARS during sample processing.
Isoprostanes
Increased circulating and urine levels of F 2 -IsoPs have been demonstrated in various cardiovascular diseases associated with vascular injury, including hypertension, atherosclerosis, ischemia-reperfusion injury, and heart failure. 344, 345 In addition, in healthy people with cardiovascular disease risk factors, such as obesity, diabetes mellitus, and hyperlipidemia, plasma concentrations of F 2 -IsoPs are elevated, 346 which suggests that indices of lipid peroxidation could be clinically relevant biomarkers of cardiovascular risk. In support of this concept, a recent prospective study that included 1002 patients with atrial fibrillation who had undergone anticoagulation therapy who were studied for 25 months demonstrated that the levels of 8-iso-PGF2α and sNOX2-dp (a marker of Nox2 levels) correlated with cardiovascular events. 347 Using various modeling paradigms, it was shown that 8-iso-PGF2α predicted cardiovascular events and death. As such, it was suggested that F 2 -IsoP might complement conventional risk factors in prediction of cardiovascular events.
4-Hydroxy-Trans-2-Nonenal
Increasing experimental evidence indicates that HNE might have a dual role as both a marker of systemic oxidative stress and a contributor to the pathogenesis of cardiovascular disease. 348, 349 Despite experimental evidence linking HNE and cardiovascular disease, there is a paucity of information in humans. A few studies in dialyzed patients demonstrated that the plasma levels of MDA and HNE correlate with severity of cardiovascular disease. 350, 351 Nonenzymatic Total Antioxidant Capacity Total antioxidant capacity (TAC) is a measure of the combined antioxidant effect of the nonenzymatic defenses in biological fluids and does not take into account the enzymatic antioxidant systems such as superoxide dismutase, catalase, and peroxidase. The assay measures low-molecular-weight antioxidants, both water soluble and lipid soluble, and includes urate, bilirubin, vitamin C, thiols, flavonoids, carotenoids, and vitamin E. 352 Experimental and clinical studies have shown, for the most part, low levels of TAC in various cardiovascular diseases. [353] [354] [355] TAC assays have also been used extensively in human studies evaluating the effects of dietary antioxidants. A recent comprehensive study reviewed prospective cohort studies and clinical trials relating to associations between plasma/dietary antioxidants (TAC) and cardiovascular events. 356, 357 In long-term, large-scale, population-based cohort studies, higher levels of TAC were associated with a lower risk of cardiovascular disease, which supports a protective effect of dietary antioxidant vitamins, carotenoids, and polyphenols. However, results from large randomized, controlled trials fail to support long-term use of single-antioxidant supplements for cardiovascular prevention because of their lack of benefit or even adverse effects on major cardiovascular events or 
NO and Peroxynitrite as Biomarkers of Endothelial Dysfunction
Biomarkers of impaired endothelial function reflect altered NO bioavailability, increased oxidative stress, coagulation, and endothelial inflammation. NO, produced by endothelial cells, is a major determinant of endothelium-dependent vasodilation and is an inhibitor of coagulation, inflammation, and oxidative stress 359, 360 and consequently has been considered as an important marker reflecting endothelial status. Because NO has a short half-life, plasma levels of oxidative degradation products of NO, including nitrite, nitrate, and nitrosothiols, have been used as surrogate indices of NO generation. 361 The most commonly used approach to assess NO breakdown products is the Griess reaction assay, which can be used in various clinical samples such as urine, plasma, serum, and cerebrospinal fluid. The Griess assay, which is now available in commercial kits, can detect nitrite levels in clinical samples as low as 0.5 mmol/L. 362, 363 NO products can also be measured with chemiluminescence and fluorescence methodology, 364, 365 but the clinical utility of these approaches is still unclear.
In addition to assessing levels of NO and its metabolites, measurement of asymmetric dimethylarginine, a potent endogenous inhibitor of NOS-derived NO production, can reflect NO bioavailability. 366 Plasma asymmetric dimethylarginine levels are measured by LC/MS 367 and have been shown to correlate with endothelial NOS activity and to be associated with endothelial dysfunction. 368, 369 Vascular injury is also associated with increased production of endothelial O 2 . − , which readily reacts with NO to form peroxynitrite (ONOO − ), an injurious free radical that further contributes to endothelial dysfunction. 370 Similarly, lipid peroxyl radicals react with NO and could also be a source of NO inactivation. 371 Plasma measures of endothelial oxidative stress include indices of lipid peroxidation (F 2 -IsoPs and TBARS) and nitrotyrosine levels, reflecting peroxynitrite generation, although these measurements are not specific for endothelial ROS production. 372 Lipid peroxidation is increased in diseases associated with endothelial dysfunction, and there is a strong negative correlation between oxidative stress and endothelial function as assessed by forearm blood flow responses to acetylcholine in the presence of the antioxidant vitamin C. 373, 374 
Recommendations for Measurement
Considering the important role of ROS and oxidative stress in the pathophysiology of cardiovascular disease, there is an increasing need to accurately measure oxidative status in the clinical setting, as well as in translational studies. Current approaches rely on the measurement of circulating biomarkers of oxidative stress (Figure 7) . However, there are limitations to using such an approach, because (1) circulating levels of ROS biomarkers reflect generalized oxidative status without any information about the tissue or enzymatic source from which the ROS are generated; (2) biomarkers are indirect indices of ROS; and (3) current methodologies lack sensitivity and specificity. Development of new analytical methodologies should focus on direct measurement of free radicals, using assays that are user-friendly, practical, and of clinical utility. Because the ideal biomarker of oxidative stress has not yet been identified, it is prudent to measure multiple independent biomarkers when evaluating ROS status in humans. A practical guide to suggested biomarkers to evaluate ROS/RNS status in the clinic is summarized in Figure 8 .
Measurements of ROS/RNS and oxidative stress are often made in the context of antioxidant supplementation; . − than the frequently used antioxidant supplement ascorbic acid. (3) Antioxidant supplements were not targeted to specific subcellular sites of ROS/RNS overproduction, such as mitochondria. It is conceivable that the use of antioxidants targeted to compartments where ROS are generated, such as the mitochondria, might be more effective. 375 Indeed, recent studies with transgenic mice support the therapeutic potential of SOD overexpression in mitochondria and cytoplasm. (4) Finally, and relevant to this statement, many of these studies lack validation of an antioxidant effect by measurement of relevant biomarkers discussed herein. Hence, in assessing changes in the oxidative stress, it is important not only to measure changes in the ROS/RNS themselves but in their secondary products as well.
Summary and Overall Recommendations
Reliable and reproducible measures of ROS/RNS are difficult to achieve given the complexity of the biological systems with which they interact, their short half-lives and high reactivity, the balance between production and antioxidant capacity, and compartmentalization of reactivity and short diffusion distances. However, these molecules have both physiological and pathological roles, and precise measurements are not only desirable but also imperative for consistency across studies. The principles and analyses in this statement provide a basis for deciding which assays to use in specific experimental conditions, as well as recommendations for common use in various settings.
As general guidance, we recommend that any method or assay used for measuring ROS or RNS should be specific, Figure 8 . Decision tree for measuring oxidant status in clinical tissue. Clinical samples (blood, tissue, urine) can be assayed for pro-oxidant and antioxidant biomarkers with a variety of bioassays. For measuring pro-oxidants, levels of lipid peroxidation or DNA damage can be measured in biological fluids. Metabolites of lipid peroxidation products (aldehydes, isoprostanes, and hydroperoxides) by gas chromatography (GC)/liquid chromatography (LC) mass spectroscopy (MS) provide the most sensitive and specific assessment of oxidative stress and are shown as 1° assays. Proteins modified by 4-hydroxy-trans-2-nonenal and malondialdehyde can also be measured by Western analysis or other immunoassays, and isoprostanes can be measured by ELISA, but these measurements are generally less sensitive and less specific (2° assays). Lipid hydroperoxides (LOOH) can also be measured by high-performance liquid chromatography (HPLC). The use of nonspecific and nonselective measurements of lipid peroxidation products (thiobarbituric reactive substances [TBARS]) is not recommended (3° assay). DNA damage can be measured by quantifying modified bases either by GC/LC/MS (1° assay), HPLC, or reverse transcription polymerase chain reaction (RT-PCR; 2° assays) or by less specific immunoassays (3° assay). Assessment of antioxidant status could involve measurements of the total antioxidant capacity (TAC) or measurement of reduced glutathione (GSH)/oxidized glutathione (GSSG) or reduced cysteine (Cys)/oxidized cysteine (CySS) ratio either by HPLC (2° assays) or by colorimetric/fluorometric techniques, although these measurements are relatively less sensitive and prone to artifacts (3° assays) than other techniques. ORAC indicates oxygen radical absorbance capacity. sensitive, and reproducible. Given the highly reactive nature of these species, care should be taken to ensure the stability of the sample during isolation, preparation, storage, and analysis, which is particularly challenging when measuring oxidative modifications that can be influenced by exposure to ambient oxygen. Because of the ephemeral nature of many of these modifications, best practice is to confirm findings with >1 assay and to use appropriate controls. In addition, we recommend that investigators choose an array of assays that directly and specifically measure the ROS of interest, as well as its particular endpoints, rather than relying on global measures of oxidative stress ( Figure 9 ). We also suggest that the values of antioxidants (such as glutathione) or products of oxidation (such as lipid peroxidation products) should be reported in absolute rather than relative values. Values of these metabolites expressed in molar concentrations are particularly useful for intertissue comparisons and for comparison of results obtained in different laboratories. 
